Cargando…

The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles

Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Feifei, Luo, Ling, Ahmad, Shiraz, Valli, Haseeb, Jeevaratnam, Kamalan, Wang, Tingzhong, Guzadhur, Laila, Yang, Dandan, Fraser, James A., Huang, Christopher L.-H., Ma, Aiqun, Salvage, Samantha C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792352/
https://www.ncbi.nlm.nih.gov/pubmed/26545784
http://dx.doi.org/10.1007/s00424-015-1750-0
_version_ 1782421226129457152
author Ning, Feifei
Luo, Ling
Ahmad, Shiraz
Valli, Haseeb
Jeevaratnam, Kamalan
Wang, Tingzhong
Guzadhur, Laila
Yang, Dandan
Fraser, James A.
Huang, Christopher L.-H.
Ma, Aiqun
Salvage, Samantha C.
author_facet Ning, Feifei
Luo, Ling
Ahmad, Shiraz
Valli, Haseeb
Jeevaratnam, Kamalan
Wang, Tingzhong
Guzadhur, Laila
Yang, Dandan
Fraser, James A.
Huang, Christopher L.-H.
Ma, Aiqun
Salvage, Samantha C.
author_sort Ning, Feifei
collection PubMed
description Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show an atrial arrhythmic phenotype associated with reduced action potential (AP) conduction velocity and sodium channel (Na(v)1.5) expression. We now relate ventricular arrhythmogenicity and slowed AP conduction in RyR2(S/S) hearts to connexin-43 (Cx43) and Na(v)1.5 expression and Na(+) current (I(Na)). Stimulation protocols applying extrasystolic S2 stimulation following 8 Hz S1 pacing at progressively decremented S1S2 intervals confirmed an arrhythmic tendency despite unchanged ventricular effective refractory periods (VERPs) in Langendorff-perfused RyR2(S/S) hearts. Dynamic pacing imposing S1 stimuli then demonstrated that progressive reductions of basic cycle lengths (BCLs) produced greater reductions in conduction velocity at equivalent BCLs and diastolic intervals in RyR2(S/S) than WT, but comparable changes in AP durations (APD(90)) and their alternans. Western blot analyses demonstrated that Cx43 protein expression in whole ventricles was similar, but Na(v)1.5 expression in both whole tissue and membrane fractions were significantly reduced in RyR2(S/S) compared to wild-type (WT). Loose patch-clamp studies similarly demonstrated reduced I(Na) in RyR2(S/S) ventricles. We thus attribute arrhythmogenesis in RyR2(S/S) ventricles resulting from arrhythmic substrate produced by reduced conduction velocity to downregulated Na(v)1.5 reducing I(Na), despite normal determinants of repolarization and passive conduction. The measured changes were quantitatively compatible with earlier predictions of linear relationships between conduction velocity and the peak I(Na) of the AP but nonlinear relationships between peak I(Na) and maximum Na(+) permeability.
format Online
Article
Text
id pubmed-4792352
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47923522016-04-09 The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles Ning, Feifei Luo, Ling Ahmad, Shiraz Valli, Haseeb Jeevaratnam, Kamalan Wang, Tingzhong Guzadhur, Laila Yang, Dandan Fraser, James A. Huang, Christopher L.-H. Ma, Aiqun Salvage, Samantha C. Pflugers Arch Molecular and Cellular Mechanisms of Disease Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show an atrial arrhythmic phenotype associated with reduced action potential (AP) conduction velocity and sodium channel (Na(v)1.5) expression. We now relate ventricular arrhythmogenicity and slowed AP conduction in RyR2(S/S) hearts to connexin-43 (Cx43) and Na(v)1.5 expression and Na(+) current (I(Na)). Stimulation protocols applying extrasystolic S2 stimulation following 8 Hz S1 pacing at progressively decremented S1S2 intervals confirmed an arrhythmic tendency despite unchanged ventricular effective refractory periods (VERPs) in Langendorff-perfused RyR2(S/S) hearts. Dynamic pacing imposing S1 stimuli then demonstrated that progressive reductions of basic cycle lengths (BCLs) produced greater reductions in conduction velocity at equivalent BCLs and diastolic intervals in RyR2(S/S) than WT, but comparable changes in AP durations (APD(90)) and their alternans. Western blot analyses demonstrated that Cx43 protein expression in whole ventricles was similar, but Na(v)1.5 expression in both whole tissue and membrane fractions were significantly reduced in RyR2(S/S) compared to wild-type (WT). Loose patch-clamp studies similarly demonstrated reduced I(Na) in RyR2(S/S) ventricles. We thus attribute arrhythmogenesis in RyR2(S/S) ventricles resulting from arrhythmic substrate produced by reduced conduction velocity to downregulated Na(v)1.5 reducing I(Na), despite normal determinants of repolarization and passive conduction. The measured changes were quantitatively compatible with earlier predictions of linear relationships between conduction velocity and the peak I(Na) of the AP but nonlinear relationships between peak I(Na) and maximum Na(+) permeability. Springer Berlin Heidelberg 2015-11-06 2016 /pmc/articles/PMC4792352/ /pubmed/26545784 http://dx.doi.org/10.1007/s00424-015-1750-0 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Molecular and Cellular Mechanisms of Disease
Ning, Feifei
Luo, Ling
Ahmad, Shiraz
Valli, Haseeb
Jeevaratnam, Kamalan
Wang, Tingzhong
Guzadhur, Laila
Yang, Dandan
Fraser, James A.
Huang, Christopher L.-H.
Ma, Aiqun
Salvage, Samantha C.
The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title_full The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title_fullStr The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title_full_unstemmed The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title_short The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
title_sort ryr2-p2328s mutation downregulates na(v)1.5 producing arrhythmic substrate in murine ventricles
topic Molecular and Cellular Mechanisms of Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792352/
https://www.ncbi.nlm.nih.gov/pubmed/26545784
http://dx.doi.org/10.1007/s00424-015-1750-0
work_keys_str_mv AT ningfeifei theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT luoling theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT ahmadshiraz theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT vallihaseeb theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT jeevaratnamkamalan theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT wangtingzhong theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT guzadhurlaila theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT yangdandan theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT fraserjamesa theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT huangchristopherlh theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT maaiqun theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT salvagesamanthac theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT ningfeifei ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT luoling ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT ahmadshiraz ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT vallihaseeb ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT jeevaratnamkamalan ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT wangtingzhong ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT guzadhurlaila ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT yangdandan ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT fraserjamesa ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT huangchristopherlh ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT maaiqun ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles
AT salvagesamanthac ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles